Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cullinan Therapeutics Inc
(NQ:
CGEM
)
15.88
-0.34 (-2.10%)
Streaming Delayed Price
Updated: 1:12 PM EDT, Oct 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cullinan Therapeutics Inc
< Previous
1
2
3
Next >
Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
September 25, 2024
Amgen reports mixed results from Phase 3 trials, with rocatinlimab showing moderate success in atopic dermatitis and Uplizna outperforming expectations in myasthenia gravis, offering less frequent...
Via
Benzinga
Merck's $1.3B Deal For Potential Autoimmune Disorder Candidate Is Relevant To Cullinan's Investigational Drug, Says Analyst
August 09, 2024
Merck has agreed to acquire CN201, a bispecific antibody from Curon Biopharmaceutical, for $700 million. This acquisition aims to advance Merck's pipeline for treating B-cell malignancies and...
Via
Benzinga
CGEM Stock Earnings: Cullinan Therapeutics Misses EPS for Q2 2024
August 08, 2024
CGEM stock results show that Cullinan Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
CGEM Stock Earnings: Cullinan Oncology Beats EPS for Q1 2024
May 15, 2024
CGEM stock results show that Cullinan Oncology beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 29, 2024
Via
Benzinga
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
April 29, 2024
Via
Benzinga
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 26, 2024
Via
Benzinga
Cullinan Oncology: Q4 Earnings Insights
March 14, 2024
Via
Benzinga
Recap: Cullinan Oncology Q3 Earnings
November 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 26, 2024
Via
Benzinga
Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday
April 26, 2024
Via
Benzinga
Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?
April 24, 2024
Explore the use of Amgen's Blincyto in treating severe systemic sclerosis, shedding light on Cullinan Therapeutics' CLN-978 potential for autoimmune diseases, particularly systemic lupus...
Via
Benzinga
Analyst Ratings for Cullinan Oncology
August 09, 2023
Via
Benzinga
Analyst Ratings for Cullinan Oncology
July 07, 2023
Via
Benzinga
Analyst Expectations for Cullinan Oncology's Future
June 15, 2023
Via
Benzinga
Expert Ratings for Cullinan Oncology
June 15, 2023
Via
Benzinga
4 Analysts Have This to Say About Cullinan Oncology
May 26, 2023
Via
Benzinga
Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday
April 24, 2024
Via
Benzinga
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 17, 2024
Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
May 22, 2023
Via
Benzinga
United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday
April 17, 2024
U.S. stocks were lower, with the Dow Jones index falling over 50 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 16, 2024
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates.
Via
Benzinga
Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity
April 16, 2024
Cullinan shifts focus to autoimmune diseases with CLN-978, targeting systemic lupus erythematosus. Initial trial results show potential for treatment with a differentiated safety profile.
Via
Benzinga
UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
April 16, 2024
U.S. stocks were mostly higher, with the Dow Jones index gaining over 100 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 16, 2024
Via
Benzinga
CGEM Stock Earnings: Cullinan Oncology Beats EPS for Q4 2023
March 14, 2024
CGEM stock results show that Cullinan Oncology beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
January 30, 2024
Shares of Super Micro Computer, Inc. (NASDAQ: SMCI) shares rose sharply in today’s pre-market trading as the company posted upbeat results for its second quarter.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
October 06, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2023
June 15, 2023
Via
Benzinga
Why Shares of Cullinan Oncology Jumped This Week
June 09, 2023
The company's presentation at a conference got the attention of analysts and investors.
Via
The Motley Fool
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.